Emergent Biosolutions
EBS
EBS
236 hedge funds and large institutions have $2.43B invested in Emergent Biosolutions in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 76 increasing their positions, 96 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 96
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
78% less call options, than puts
Call options by funds: $582K | Put options by funds: $2.66M
Holders
236
Holding in Top 10
1
Calls
$582K
Puts
$2.66M
Top Buyers
| 1 | +$16.2M | |
| 2 | +$15.6M | |
| 3 | +$15.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$11.6M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$9.63M |
Top Sellers
| 1 | -$19M | |
| 2 | -$16.1M | |
| 3 | -$11.9M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.1M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$10.1M |